ロード中...
Spironolactone mitigates, but does not reverse, the progression of renal fibrosis in a transgenic hypertensive rat
Hypertension plays an important role in the development and progression of chronic kidney disease. Studies to date, with mineralocorticoid receptor antagonists (MRA), have demonstrated varying degrees of results in modifying the development of renal fibrosis. This study aimed to investigate whether...
保存先:
| 出版年: | Physiol Rep |
|---|---|
| 主要な著者: | , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
John Wiley and Sons Inc.
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7243196/ https://ncbi.nlm.nih.gov/pubmed/32441493 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.14814/phy2.14448 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|